$13.38
3.2131.56%
Last update: Nov 9, 5:40 PM
Iambic Therapeutics Inc
IAMNASDAQ
Market sentiment signals for Iambic Therapeutics (IAM): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
3 analysts
Options Flow (P/C)
—
Avg Consensus PT
$25
+79.6%
Highest Price Target
$30
+118.4%
Lowest Price Target
$22
+60.2%
Short Interest
—
Insider Activity (30d)
Net Buyer
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | JP Morgan | —— | +60.2% | $22 | Initiate | Overweight |
| Nov 9, 2026 | Citigroup | Geoff Meacham— | +60.2% | $22 | Initiate | Buy |
